title: Detrusor myocyte activity and afferent signaling.
abstract: OBJECTIVE
  To discuss (1) mechanisms involved in the generation and control of myocyte contractions and consequent afferent nerve activity and (2) these mechanisms as targets for drugs aimed for treatment of overactive bladder (OAB) symptoms and detrusor overactivity (DO).
  
  
  METHODS
  Literature review of myocyte activation, bladder afferent nerves, mediators in the bladder, and translational aspects of the findings.
  
  
  RESULTS
  During bladder filling, there is normally no parasympathetic outflow from the spinal cord. Despite this, the bladder develops tone during filling and also exhibits non-synchronized local contractions and relaxations that are caused by a basal myogenic mechanical activity that may be reinforced by release of, for example, acetylcholine from non-neuronal and/or neuronal sources or local mediators, such as prostaglandins and endothelins. It is suggested that these spontaneous contractions are able to generate activity in afferent nerves ("afferent noise") that may contribute to DO and OAB.
  
  
  CONCLUSIONS
  Spontaneous bladder myocyte contractions and factors that are able to modulate them, as well as the consequent afferent nerve activity, may be targets for drugs meant for treatment of OAB/DO.
authors.affiliation: Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. karl-erik.andersson@klinfarm.lu.se
authors.forename: Karl-Erik
authors.initials: KE
authors.lastname: Andersson
mesh_terms: D000344:Afferent Pathways / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D000818:Animals; D002450:Cell Communication; D017629:Gap Junctions / Q000378:metabolism; D006801:Humans; D056885:Interstitial Cells of Cajal / Q000378:metabolism; D040542:Mechanotransduction, Cellular / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009126:Muscle Relaxation; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation*; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism*; D001743:Urinary Bladder / Q000187:drug effects / Q000294:innervation*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*